Purpose
This Notice of Funding Opportunity (NOFO) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-in
PAR-24-066 : NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
Release Date: 2023-11-30
Grant Status: open
Due Date: Multiple
2024-01-30
2024-05-24
2024-09-23
2025-01-24
2025-05-28
2025-09-23
2026-01-24
2026-05-27
2026-09-23
Close Date: 2027-01-08
Description
This Notice of Funding Opportunity (NOFO) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated c
PAR-24-158 : Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
Release Date: 2024-02-29
Grant Status: open
Due Date: Multiple
2024-09-05
2025-01-05
2025-04-05
2025-09-05
2026-01-05
2026-04-05
2026-09-05
2027-01-05
Close Date: 2027-01-06
Description
Introduction
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), works to catalyze the generation of innovative methods and technologies that
PAR-24-157 : Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Release Date: 2024-02-29
Grant Status: open
Due Date: Multiple
2024-09-05
2025-01-05
2025-04-05
2025-09-05
2026-01-05
2026-04-05
2026-09-05
2027-01-05
Close Date: 2027-01-06
Description
Introduction
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), works to catalyze the generation of innovative methods and technologies that
RFA-MD-24-006 : Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Release Date: 2024-03-08
Grant Status: open
Due Date: Multiple
2024-06-10
2024-12-10
2025-06-10
2025-12-09
2026-06-10
2026-12-09
Close Date: 2026-12-10
Description
Background
Despite continued improvement in the health of the U.S. population with the introduction of medical and scientific advances, there continues to be an alarming disproportionate burden of
2024 : Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Release Date: 2024-03-08
Grant Status: open
Due Date: Multiple
2024-06-10
2024-12-10
2025-06-10
2025-12-09
2026-06-10
2026-12-09
Close Date: 2026-12-10
Description
Background
Despite continued improvement in the health of the U.S. population with the introduction of medical and scientific advances, there continues to be an alarming disproportionate burden of
PAR-24-044 : NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Release Date: 2023-11-27
Grant Status: open
Due Date: Multiple
2024-01-05
2024-04-05
2024-09-05
2025-01-05
2025-04-05
2025-09-05
2026-01-05
2026-04-05
2026-09-05
Close Date: 2026-09-06
Description
NINDS is committed to advancing diagnostics and treatments for people burdened by neurological diseases, and the NINDS Small Business Innovation Research (SBIR) and Small Business Technology Transfer
PAR-23-311 : NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Release Date: 2023-11-27
Grant Status: open
Due Date: Multiple
2024-01-05
2024-04-05
2024-09-05
2025-01-05
2025-04-05
2025-09-05
2026-01-05
2026-04-05
2026-09-05
Close Date: 2026-09-06
Description
NINDS is committed to advancing diagnostics and treatments for people burdened by neurological diseases, and the NINDS Small Business Innovation Research (SBIR) and Small Business Technology Transfer
PAR-24-063 : Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Release Date: 2023-11-01
Grant Status: open
Due Date: Multiple
2024-02-09
2024-07-15
2025-01-15
2025-07-15
2026-01-15
2026-07-15
Close Date: 2026-08-19
Description
Recent advances in neuroscience offer unprecedented opportunities to discover new treatments for nervous system disorders. However, before a new chemical entity can be tested in a clinical setting, it
PAR-24-098 : Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
Release Date: 2024-01-22
Grant Status: open
Due Date: Multiple
2024-03-22
2024-06-21
2025-02-21
2025-06-20
2026-02-20
2026-06-22
Close Date: 2026-06-26
Description
Background
A biomarker is a defined characteristic that is measured as an indicator of a normal biological process, pathogenic process, or responses to an exposure or intervention, including therap